PCI Pharma Services

PCI Pharma Services is a global CDMO that delivers end‑to‑end drug development and manufacturing solutions across 38 sites with more than 8,000 employees. Its core focus includes advanced drug delivery, device‑combination products, clinical trial manufacturing, sterile fill‑finish, lyophilization, and commercial packaging. The company differentiates itself through integrated global services, cutting‑edge technology, and a commitment to intelligence, ingenuity, and innovation that streamline the journey from early development to commercialization. PCI Pharma Services partners with biopharmaceuticals to create life‑changing therapies, offering seamless, quality‑centric solutions that enhance patient outcomes worldwide.